Valuation: Principal Technologies Inc.

Market Cap 16.45M 11.68M 10.26M 9.54M 8.76M 1.13B 16.71M 113M 44.27M 553M 43.85M 42.91M 1.91B P/E 2024 *
-
P/E 2025 -2x
Enterprise Value 15.45M 10.97M 9.63M 8.96M 8.22M 1.06B 15.69M 106M 41.57M 519M 41.18M 40.29M 1.8B EV / Sales 2024
7,172,726x
EV / Sales 2025 25,290,400x
Free-Float
66.64%
Yield 2024 *
-
Yield 2025 -
3 years 0
Extreme 0
0.27
5 years 0
Extreme 0
0.27
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 47 2021-08-03
Director of Finance/CFO 70 2023-03-05
Director TitleAgeSince
Chairman 55 -
Director/Board Member 70 2021-08-03
Director/Board Member 47 2021-08-03
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 13.21M
+1.07%-3.49%-3.25%+12.87% 46.35B
+0.25%+1.65%+408.41%+629.49% 40.13B
-0.27%+4.45%+9.93%+66.92% 36.33B
+0.35%+0.87%+3.60%-8.81% 34.6B
+3.14%+1.02%+3.37%+38.15% 26.77B
-0.73%+11.84%+31.97%+143.53% 16.91B
+0.47%-2.74% - - 16.66B
+0.42%-5.52%+0.76%+8.50% 13.05B
-2.68%-2.49%-15.00%-31.68% 13.05B
Average +0.20%+0.99%+54.97%+107.37% 27.09B
Weighted average by Cap. +0.46%+1.10%+75.57%+137.02%

Financials

2024 2025
Net sales 0.66 0.47 0.41 0.39 0.35 45.41 0.67 4.57 1.79 22.32 1.77 1.73 77.18 0.37 0.26 0.23 0.21 0.2 25.33 0.38 2.55 1 12.45 0.99 0.97 43.06
Net income -1.62M -1.15M -1.01M -937K -860K -110M -1.64M -11.12M -4.35M -54.3M -4.31M -4.21M -188M -4.24M -3.01M -2.64M -2.46M -2.25M -290M -4.3M -29.17M -11.4M -142M -11.29M -11.05M -492M
Net Debt -767K -545K -479K -445K -408K -52.48M -779K -5.29M -2.06M -25.8M -2.05M -2M -89.2M -1M -712K -626K -582K -534K -68.59M -1.02M -6.91M -2.7M -33.72M -2.67M -2.62M -117M
Logo Principal Technologies Inc.
Principal Technologies Inc. is a Canada-based healthcare acquisition company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The Company operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
Employees
-